ID   ALDOC_HUMAN             Reviewed;         364 AA.
AC   P09972; B2R5R3; Q3SYL3; Q6FH94; Q6P0L5;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Fructose-bisphosphate aldolase C;
DE            EC=4.1.2.13;
DE   AltName: Full=Brain-type aldolase;
GN   Name=ALDOC; Synonyms=ALDC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3105602; DOI=10.1016/0300-9084(87)90246-X;
RA   Rottmann W.H., Deselms K.R., Niclas J., Camerato T., Holman P.S.,
RA   Green C.J., Tolan D.R.;
RT   "The complete amino acid sequence of the human aldolase C isozyme
RT   derived from genomic clones.";
RL   Biochimie 69:137-145(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3267224; DOI=10.1093/nar/16.10.4733;
RA   Buono P., Paolella G., Mancini F.P., Izzo P., Salvatore F.;
RT   "The complete nucleotide sequence of the gene coding for the human
RT   aldolase C.";
RL   Nucleic Acids Res. 16:4733-4733(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2209624; DOI=10.1111/j.1432-1033.1990.tb19294.x;
RA   Buono P., Mancini F.P., Izzo P., Salvatore F.;
RT   "Characterization of the transcription-initiation site and of the
RT   promoter region within the 5' flanking region of the human aldolase C
RT   gene.";
RL   Eur. J. Biochem. 192:805-811(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Eye, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH ATP6V1E1.
RX   PubMed=11399750; DOI=10.1074/jbc.M008768200;
RA   Lu M., Holliday L.S., Zhang L., Dunn W.A. Jr., Gluck S.L.;
RT   "Interaction between aldolase and vacuolar H+-ATPase: evidence for
RT   direct coupling of glycolysis to the ATP-hydrolyzing proton pump.";
RL   J. Biol. Chem. 276:30407-30413(2001).
RN   [11]
RP   INTERACTION WITH PLD2.
RX   PubMed=11876650; DOI=10.1021/bi015700a;
RA   Kim J.H., Lee S., Kim J.H., Lee T.G., Hirata M., Suh P.-G., Ryu S.H.;
RT   "Phospholipase D2 directly interacts with aldolase via its PH
RT   domain.";
RL   Biochemistry 41:3414-3421(2002).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-111, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-39 AND SER-45,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 1-364, CATALYTIC ACTIVITY,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15537755; DOI=10.1110/ps.04915904;
RA   Arakaki T.L., Pezza J.A., Cronin M.A., Hopkins C.E., Zimmer D.B.,
RA   Tolan D.R., Allen K.N.;
RT   "Structure of human brain fructose 1,6-(bis)phosphate aldolase:
RT   linking isozyme structure with function.";
RL   Protein Sci. 13:3077-3084(2004).
CC   -!- CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate = glycerone
CC       phosphate + D-glyceraldehyde 3-phosphate.
CC       {ECO:0000269|PubMed:15537755}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.7 uM for fructose 1,6-bisphosphate
CC         {ECO:0000269|PubMed:15537755};
CC         KM=16 mM for fructose 1-phosphate {ECO:0000269|PubMed:15537755};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate and glycerone phosphate from D-glucose: step 4/4.
CC   -!- SUBUNIT: Homotetramer. Interacts with ATP6V1E1. May interact with
CC       PLD2. {ECO:0000269|PubMed:11399750, ECO:0000269|PubMed:11876650}.
CC   -!- INTERACTION:
CC       P04075-2:ALDOA; NbExp=6; IntAct=EBI-2952751, EBI-10194102;
CC       Q8TBB1:LNX1; NbExp=5; IntAct=EBI-2952751, EBI-739832;
CC   -!- MISCELLANEOUS: In vertebrates, three forms of this ubiquitous
CC       glycolytic enzyme are found, aldolase A in muscle, aldolase B in
CC       liver and aldolase C in brain.
CC   -!- SIMILARITY: Belongs to the class I fructose-bisphosphate aldolase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI03761.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X05196; CAA28825.1; -; Genomic_DNA.
DR   EMBL; X07292; CAA30270.1; -; Genomic_DNA.
DR   EMBL; AF054987; AAC09348.1; -; mRNA.
DR   EMBL; BT007006; AAP35652.1; -; mRNA.
DR   EMBL; CR541862; CAG46660.1; -; mRNA.
DR   EMBL; CR541881; CAG46679.1; -; mRNA.
DR   EMBL; AK312281; BAG35210.1; -; mRNA.
DR   EMBL; CH471159; EAW51104.1; -; Genomic_DNA.
DR   EMBL; BC003613; AAH03613.3; -; mRNA.
DR   EMBL; BC103760; AAI03761.1; ALT_INIT; mRNA.
DR   EMBL; BC065565; AAH65565.2; -; mRNA.
DR   EMBL; BC106925; AAI06926.1; -; mRNA.
DR   EMBL; BC106926; AAI06927.1; -; mRNA.
DR   CCDS; CCDS11236.1; -.
DR   PIR; A25861; ADHUC.
DR   RefSeq; NP_005156.1; NM_005165.2.
DR   RefSeq; XP_005258006.1; XM_005257949.2.
DR   RefSeq; XP_011522858.1; XM_011524556.1.
DR   UniGene; Hs.155247; -.
DR   PDB; 1XFB; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L=1-364.
DR   PDBsum; 1XFB; -.
DR   ProteinModelPortal; P09972; -.
DR   SMR; P09972; -.
DR   BioGrid; 106731; 68.
DR   IntAct; P09972; 8.
DR   STRING; 9606.ENSP00000226253; -.
DR   iPTMnet; P09972; -.
DR   PhosphoSitePlus; P09972; -.
DR   SwissPalm; P09972; -.
DR   BioMuta; ALDOC; -.
DR   DMDM; 113613; -.
DR   UCD-2DPAGE; P09972; -.
DR   EPD; P09972; -.
DR   MaxQB; P09972; -.
DR   PaxDb; P09972; -.
DR   PeptideAtlas; P09972; -.
DR   PRIDE; P09972; -.
DR   DNASU; 230; -.
DR   Ensembl; ENST00000226253; ENSP00000226253; ENSG00000109107.
DR   Ensembl; ENST00000395321; ENSP00000378731; ENSG00000109107.
DR   GeneID; 230; -.
DR   KEGG; hsa:230; -.
DR   UCSC; uc002hbp.4; human.
DR   CTD; 230; -.
DR   DisGeNET; 230; -.
DR   GeneCards; ALDOC; -.
DR   HGNC; HGNC:418; ALDOC.
DR   HPA; CAB020828; -.
DR   HPA; HPA003282; -.
DR   HPA; HPA067442; -.
DR   MIM; 103870; gene.
DR   neXtProt; NX_P09972; -.
DR   OpenTargets; ENSG00000109107; -.
DR   PharmGKB; PA24711; -.
DR   eggNOG; KOG1557; Eukaryota.
DR   eggNOG; COG3588; LUCA.
DR   GeneTree; ENSGT00390000010235; -.
DR   HOVERGEN; HBG002386; -.
DR   InParanoid; P09972; -.
DR   KO; K01623; -.
DR   OMA; WRGQQDN; -.
DR   OrthoDB; EOG091G0A9T; -.
DR   PhylomeDB; P09972; -.
DR   TreeFam; TF314203; -.
DR   BioCyc; MetaCyc:HS03200-MONOMER; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P09972; -.
DR   UniPathway; UPA00109; UER00183.
DR   ChiTaRS; ALDOC; human.
DR   EvolutionaryTrace; P09972; -.
DR   GeneWiki; Aldolase_C; -.
DR   GenomeRNAi; 230; -.
DR   PRO; PR:P09972; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000109107; -.
DR   CleanEx; HS_ALDOC; -.
DR   ExpressionAtlas; P09972; baseline and differential.
DR   Genevisible; P09972; HS.
DR   GO; GO:0005856; C:cytoskeleton; IC:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL.
DR   GO; GO:0004332; F:fructose-bisphosphate aldolase activity; IDA:UniProtKB.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030388; P:fructose 1,6-bisphosphate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006000; P:fructose metabolic process; TAS:ProtInc.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR029768; Aldolase_I_AS.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR000741; FBA_I.
DR   Pfam; PF00274; Glycolytic; 1.
DR   PROSITE; PS00158; ALDOLASE_CLASS_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Glycolysis; Lyase;
KW   Phosphoprotein; Reference proteome; Schiff base.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P09117}.
FT   CHAIN         2    364       Fructose-bisphosphate aldolase C.
FT                                /FTId=PRO_0000216947.
FT   ACT_SITE    188    188       Proton acceptor. {ECO:0000250}.
FT   ACT_SITE    230    230       Schiff-base intermediate with
FT                                dihydroxyacetone-P.
FT   BINDING      56     56       Substrate.
FT   BINDING     147    147       Substrate.
FT   SITE        364    364       Necessary for preference for fructose
FT                                1,6-bisphosphate over fructose 1-
FT                                phosphate.
FT   MOD_RES      36     36       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      39     39       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      45     45       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     111    111       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   CONFLICT    311    311       L -> V (in Ref. 2; CAA30270).
FT                                {ECO:0000305}.
FT   HELIX        10     23       {ECO:0000244|PDB:1XFB}.
FT   STRAND       29     33       {ECO:0000244|PDB:1XFB}.
FT   HELIX        37     45       {ECO:0000244|PDB:1XFB}.
FT   HELIX        53     64       {ECO:0000244|PDB:1XFB}.
FT   HELIX        68     70       {ECO:0000244|PDB:1XFB}.
FT   TURN         71     73       {ECO:0000244|PDB:1XFB}.
FT   STRAND       74     79       {ECO:0000244|PDB:1XFB}.
FT   HELIX        82     85       {ECO:0000244|PDB:1XFB}.
FT   HELIX        94    100       {ECO:0000244|PDB:1XFB}.
FT   STRAND      104    108       {ECO:0000244|PDB:1XFB}.
FT   STRAND      113    115       {ECO:0000244|PDB:1XFB}.
FT   STRAND      119    121       {ECO:0000244|PDB:1XFB}.
FT   STRAND      123    125       {ECO:0000244|PDB:1XFB}.
FT   HELIX       131    140       {ECO:0000244|PDB:1XFB}.
FT   STRAND      145    152       {ECO:0000244|PDB:1XFB}.
FT   HELIX       161    179       {ECO:0000244|PDB:1XFB}.
FT   TURN        180    182       {ECO:0000244|PDB:1XFB}.
FT   STRAND      184    191       {ECO:0000244|PDB:1XFB}.
FT   HELIX       199    219       {ECO:0000244|PDB:1XFB}.
FT   HELIX       224    226       {ECO:0000244|PDB:1XFB}.
FT   HELIX       246    257       {ECO:0000244|PDB:1XFB}.
FT   TURN        258    260       {ECO:0000244|PDB:1XFB}.
FT   STRAND      267    271       {ECO:0000244|PDB:1XFB}.
FT   HELIX       277    288       {ECO:0000244|PDB:1XFB}.
FT   STRAND      295    303       {ECO:0000244|PDB:1XFB}.
FT   HELIX       304    314       {ECO:0000244|PDB:1XFB}.
FT   HELIX       321    338       {ECO:0000244|PDB:1XFB}.
FT   TURN        339    341       {ECO:0000244|PDB:1XFB}.
SQ   SEQUENCE   364 AA;  39456 MW;  506A570B3E507971 CRC64;
     MPHSYPALSA EQKKELSDIA LRIVAPGKGI LAADESVGSM AKRLSQIGVE NTEENRRLYR
     QVLFSADDRV KKCIGGVIFF HETLYQKDDN GVPFVRTIQD KGIVVGIKVD KGVVPLAGTD
     GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKISERTPS ALAILENANV LARYASICQQ
     NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HVYLEGTLLK PNMVTPGHAC
     PIKYTPEEIA MATVTALRRT VPPAVPGVTF LSGGQSEEEA SFNLNAINRC PLPRPWALTF
     SYGRALQASA LNAWRGQRDN AGAATEEFIK RAEVNGLAAQ GKYEGSGEDG GAAAQSLYIA
     NHAY
//
